Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
NCT05322148
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free
Sponsor
Research Insight LLC